Cytodyn Inc (CYDY)

[Learning53]

This is strictly conjectural but...

If you've taken the time to listen to Dr. Richard "Randy" Nicolas and read about him, you'll discover he has carefully read and considered most of the available information/material on leronlimab. He was putting his license and his reputation on the line when he encouraged leronlimab's usage in the Philippines. He wasn't leaving things open to chance!

At the same time, I suspect Dr. Nicolas read about many of the other potential indications leronlimab is a "key" to.

Reading between the lines...he knows leronlimab is relatively harmless, so it's only a matter of time before leronlimab is tried in an "off-label" (so to speak) usage. How soon will this happen, is anybody's guess, but I'd be very surprised if it didn't occur.

A successful off-label use could have some provocative ramifications.

The door is starting to "crack" open...